Members of the committee

‎‎Committee members

Finland

Professor Esa Korpi, Department of Pharmacology, University of Helsinki

Research Professor Markus Perola, National Institute for Health and Welfare

Norway

Professor Ole A. Andreassen, Institute of Clinical Medicine, University of Oslo

Professor Guri Rørtveit, Head of department, Department of Global Public Health and Primary Care, University of Bergen

Denmark

Professor Helle Prætorius Øhrwald (Chair of NOS-M), Department of Biomedicine, Aarhus University

Professor Peter Rossing, Steno Diabetes Center Copenhagen, Iceland

Iceland

Professor Saedis Saevarsdottir, Faculty of Medicine, School of Health Sciences, University of Iceland

Professor Emeritus Sigurður Guðmundsson, Faculty of Medicine, School of Health Sciences, University of Iceland

Sweden

Professor Madeleine Durbeej-Hjalt, Secretary General, Medicine and Health, Swedish Research Council

Professor Niklas Arnberg, Department of Clinical Microbiology, Umeå University

Professor Louise von Essen, Department of Women’s and Children’s Health, Uppsala University

Administrative members

Finland

Sara Illman, Biosciences, Health and Environment, The Academy of Finland

Norway

Ole Johan Borge, Director, Department for Health Research and Health Innovation, The Research Council of Norway

Karianne Solaas, Department for Health Research and Health Innovation, The Research Council of Norway

Denmark

Astrid Gro Pedersen, Office of the Independent Research Fund, Ministry of Higher Education and Science

Iceland

Ása Guðrún Kristjánsdóttir (on leave), Division for Science and Innovation, Icelandic Centre for Research – RANNÍS

Sweden

Louise Rügheimer, Coordinator Medicine and Health, Swedish Research Council

Observers

NordForsk

Maria Nilsson, Special Adviser

Estonia

Irja Lutsar, Head of the Institute of Microbiology, University of Tartu

Latvia

Kristine Klavina, Head of the Division of Strategic Planning, Ministry of Health of Latvia

Lithuania

Professor Edgaras Stankevičius, Head of Laboratory of preclinical drug investigation, Institute of Cardiology, Lithuanian University of Health Sciences